"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Descriptor ID |
D002318
|
MeSH Number(s) |
C14
|
Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1995 | 3 | 0 | 3 |
1996 | 4 | 1 | 5 |
1997 | 6 | 1 | 7 |
1998 | 2 | 2 | 4 |
1999 | 2 | 3 | 5 |
2000 | 6 | 2 | 8 |
2001 | 1 | 0 | 1 |
2002 | 5 | 5 | 10 |
2003 | 11 | 11 | 22 |
2004 | 35 | 11 | 46 |
2005 | 21 | 11 | 32 |
2006 | 34 | 9 | 43 |
2007 | 35 | 10 | 45 |
2008 | 30 | 12 | 42 |
2009 | 37 | 17 | 54 |
2010 | 30 | 15 | 45 |
2011 | 50 | 19 | 69 |
2012 | 43 | 24 | 67 |
2013 | 55 | 17 | 72 |
2014 | 67 | 16 | 83 |
2015 | 58 | 16 | 74 |
2016 | 75 | 20 | 95 |
2017 | 55 | 14 | 69 |
2018 | 77 | 15 | 92 |
2019 | 83 | 11 | 94 |
2020 | 84 | 14 | 98 |
2021 | 86 | 15 | 101 |
2022 | 91 | 1 | 92 |
2023 | 93 | 1 | 94 |
2024 | 18 | 0 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer. Tex Heart Inst J. 2024 Apr 09; 51(1).
-
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024 Apr 01; 45(13):1173-1176.
-
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database. Eur J Prev Cardiol. 2024 Mar 27; 31(5):e33-e35.
-
Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT. J Am Heart Assoc. 2024 Mar 19; 13(6):e032493.
-
In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med. 2024 Mar; 177(3):JC31.
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2024 Apr; 26(4):119-131.
-
Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV. Endocr Rev. 2024 Mar 04; 45(2):190-209.
-
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol. JAMA Cardiol. 2024 Mar 01; 9(3):263-271.
-
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood Adv. 2024 Feb 27; 8(4):909-915.
-
Association of Lifestyle Intervention With Risk for Cardiovascular Events Differs by Level of Glycated Hemoglobin. J Clin Endocrinol Metab. 2024 Feb 20; 109(3):e1012-e1019.